Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04841343 · ClinicalTrials.gov registry record
Triamcinolone Packing Following Endoscopic Sinus Surgery
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 22
- Enrollment target
NCT04841343 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 22 participants.
The verdict
NCT04841343 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
Endoscopic sinus surgery (ESS) is a well-established treatment strategy for medically refractory chronic rhinosinusitis. Middle meatus spacers are currently used following ESS to prevent scarring, synechiae formation, and middle turbinate lateralization. A 2012 systematic review favored spacers compared to no spacers, with a follow up 2013 systematic review finding no difference between the use of absorbable and non-absorbable spacers. This review, however, noted that steroidal spacers may reduce middle meatus scarring and adhesions. More recent data has shown the effectiveness of steroid releasing middle meatus implants in preventing middle turbinate lateralization, reducing synechiae formation, and reducing revision surgery. However, these stents are costly, and may result in excess crusting postoperatively, which limits their use in some settings. Another study investigated the use of steroid-impregnated absorbable packing materials, and demonstrated the safety and utility of this method of middle meatus packing. However, a limitation to this study was overall low enrollment with only 19 total patients enrolled. The purpose of this project is to add to the existing body of evidence regarding middle meatus spacers, by studying the impact of steroid impregnated, bioabsorbable hemostatic packing (Hemopore®, Stryker) on postoperative visualization and scar formation.
Interventions
- DRUG Triamcinolone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2021-01-29 |
| Est. Completion | 2022-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04841343
The ClinicalTrials.gov registry entry for NCT04841343 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Triamcinolone is the first listed.
NCT04841343 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04841343 about?
NCT04841343 is a clinical study titled "Triamcinolone Packing Following Endoscopic Sinus Surgery". Endoscopic sinus surgery (ESS) is a well-established treatment strategy for medically refractory chronic rhinosinusitis. Middle meatus spacers are currently used following ESS to prevent scarring, synechiae formation, and middle turbinate lateralization. A 2012 systematic review favored spacers comp...
What is the current status of trial NCT04841343?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2021-01-29. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT04841343?
The interventions under investigation include: Triamcinolone (DRUG).
Who is sponsoring clinical trial NCT04841343?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.